Retinoblastoma
|
Retinoblastoma
Retinoblastoma Curtis E. Margo, MD, MPH, Lynn E. Harman, MD, and Zuber D. Mulla, MSPH Although treatment outcomes for retinoblastoma have improved, patients with a germline gene mutation carry a high risk for second cancers. Background: Retinoblastoma is the most common intraocular malignancy of infants and children. With early diagnosis and treatment, survival is greater than 90%; however, ...
|
| |
Organizations